Since β-AR is expressed in the pulmonary bronchus and pancreas, β-AR blockers cause bronchial smooth muscle contraction and inhibition of insulin release, leading to bronchospasm and glucose intolerance [67, 68]. This evidence concerns the gene INS and Glucose intolerance.